tiprankstipranks
Trending News
More News >
Glenmark Life Sciences Limited (IN:GLS)
:GLS
India Market
Advertisement

Glenmark Life Sciences Limited (GLS) Price & Analysis

Compare
3 Followers

GLS Stock Chart & Stats


GLS FAQ

What was Glenmark Life Sciences Limited’s price range in the past 12 months?
Glenmark Life Sciences Limited lowest stock price was ₹827.10 and its highest was ₹1335.00 in the past 12 months.
    What is Glenmark Life Sciences Limited’s market cap?
    Glenmark Life Sciences Limited’s market cap is ₹116.63B.
      When is Glenmark Life Sciences Limited’s upcoming earnings report date?
      Glenmark Life Sciences Limited’s upcoming earnings report date is Oct 17, 2025 which is in 69 days.
        How were Glenmark Life Sciences Limited’s earnings last quarter?
        Glenmark Life Sciences Limited released its earnings results on Aug 01, 2025. The company reported ₹9.7 earnings per share for the quarter, missing the consensus estimate of ₹10.9 by -₹1.2.
          Is Glenmark Life Sciences Limited overvalued?
          According to Wall Street analysts Glenmark Life Sciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Glenmark Life Sciences Limited pay dividends?
            Glenmark Life Sciences Limited pays a Semiannually dividend of ₹22.5 which represents an annual dividend yield of 3.96%. See more information on Glenmark Life Sciences Limited dividends here
              What is Glenmark Life Sciences Limited’s EPS estimate?
              Glenmark Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Glenmark Life Sciences Limited have?
              Glenmark Life Sciences Limited has 122,629,150 shares outstanding.
                What happened to Glenmark Life Sciences Limited’s price movement after its last earnings report?
                Glenmark Life Sciences Limited reported an EPS of ₹9.7 in its last earnings report, missing expectations of ₹10.9. Following the earnings report the stock price went down -2.82%.
                  Which hedge fund is a major shareholder of Glenmark Life Sciences Limited?
                  Currently, no hedge funds are holding shares in IN:GLS

                  Company Description

                  Glenmark Life Sciences Limited

                  Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin for diabetes; and Etoricoxib and Lornoxicam for pain management. It also provides Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas. In addition, the company offers contract development and manufacturing services to a range of multinational pharmaceutical and specialty pharmaceutical companies. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited.

                  Glenmark Life Sciences Limited (GLS) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Caplin Point Laboratories Limited
                  Granules India Limited
                  Marksans Pharma Limited
                  Sanofi India Limited
                  Shilpa Medicare Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis